J F Robertson|C C Cummings - JoVE Visualize

Showing results (61-70 of 189) with videos related to

Pageof 19

Sort By:

Mutation Research|August 1, 1987

Tests for urethane induction of germ-cell mutations and germ-cell killing in the mouseL B Russell, P R Hunsicker, E F Oakberg, et al.

Breast Cancer Research and Treatment|February 16, 2000

Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancerJ F Robertson, A Howell, A Buzdar, et al.

British Journal of Cancer|June 1, 1991

Failure of CA19-9 to detect asymptomatic colorectal carcinomaW M Thomas, J F Robertson, M R Price, et al.

American Journal of Clinical Oncology|October 1, 1989

Mitoxantrone--a useful palliative therapy in advanced breast cancerJ F Robertson, M R Williams, J H Todd, et al.

American Heart Journal|October 2, 2001

Uniform platelet activation exists before coronary stent implantation despite aspirin therapyV L Serebruany, C C Cummings, A I Malinin, et al.

Journal of Pediatric Orthopedics|September 27, 2016

Prognostication in Developmental Dysplasia of the Hip Using the Ossific Nucleus Center Edge AngleGregory B Firth, Anthony J F Robertson, Yammesh Ramguthy, et al.

The Journal of Bone and Joint Surgery. British Volume|January 1, 1993

Timing of antibiotic administration in knee replacement under tourniquetJ B Richardson, A Roberts, J F Robertson, et al.

British Journal of Cancer|July 17, 1999

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenograftsE Jacobs, S A Watson, D Michaeli, et al.

European Journal of Cancer (Oxford, England : 1990)|August 17, 1999

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancerJ F Robertson, P C Willsher, L Winterbottom, et al.

Anticancer Research|May 1, 1997

Evaluation of the IMMULITE BR-MA and CEA assays and comparison with immunoradiometric assays for CA15-3 and CEA in breast cancerA Murray, P Willsher, M R Price, et al.

Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:

Pageof 19

Mutation Research|August 1, 1987

Tests for urethane induction of germ-cell mutations and germ-cell killing in the mouseL B Russell, P R Hunsicker, E F Oakberg, et al.

Breast Cancer Research and Treatment|February 16, 2000

Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancerJ F Robertson, A Howell, A Buzdar, et al.

British Journal of Cancer|June 1, 1991

Failure of CA19-9 to detect asymptomatic colorectal carcinomaW M Thomas, J F Robertson, M R Price, et al.

American Journal of Clinical Oncology|October 1, 1989

Mitoxantrone--a useful palliative therapy in advanced breast cancerJ F Robertson, M R Williams, J H Todd, et al.

American Heart Journal|October 2, 2001

Uniform platelet activation exists before coronary stent implantation despite aspirin therapyV L Serebruany, C C Cummings, A I Malinin, et al.

Journal of Pediatric Orthopedics|September 27, 2016

Prognostication in Developmental Dysplasia of the Hip Using the Ossific Nucleus Center Edge AngleGregory B Firth, Anthony J F Robertson, Yammesh Ramguthy, et al.

The Journal of Bone and Joint Surgery. British Volume|January 1, 1993

Timing of antibiotic administration in knee replacement under tourniquetJ B Richardson, A Roberts, J F Robertson, et al.

British Journal of Cancer|July 17, 1999

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenograftsE Jacobs, S A Watson, D Michaeli, et al.

European Journal of Cancer (Oxford, England : 1990)|August 17, 1999

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancerJ F Robertson, P C Willsher, L Winterbottom, et al.

Anticancer Research|May 1, 1997

Evaluation of the IMMULITE BR-MA and CEA assays and comparison with immunoradiometric assays for CA15-3 and CEA in breast cancerA Murray, P Willsher, M R Price, et al.

Pageof 19